Peptide Partners
Retatrutide
Finnrick tested 16 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Peptide Partners between 17 Jul 2025 and 2 Mar 2026. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).
Finnrick Rating™
Peptide Partners
Retatrutide
Tested 16 Samples
Last test 2 Mar 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Peptide Partners
Samples are tested in commercial labs
Tests Count
16
Scores
AVGMINMAX
Last
2 Mar 2026
First
17 Jul 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 2 Mar 2026 | View | 24mg | 22.3mg | -7.1% | 99.90% | RT202602 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 1 Mar 2026 | View | 30mg | 23.9mg | -20.3% | 99.80% | RP260130 | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 22 Feb 2026 | View | 24mg | 23.3mg | -2.9% | 99.65% | RT202602 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 29 Jan 2026 | View | 24mg | 23.1mg | -3.8% | 99.73% | RP202511 | White Label / Silver Crimp / Black Cap | Lab E | Public | |
| 26 Jan 2026 | View | 30mg | 23.9mg | -20.3% | 99.98% | TZ60GRGR121725 | White Label / Black Crimp / Clear Green Cap | Lab G | Public | |
| 17 Nov 2025 | View | 20mg | 19.5mg | -2.5% | 99.11% | CD20250708 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 9 Oct 2025 | View | 20mg | 19.6mg | -2.0% | 99.60% | cd20250708 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 9 Oct 2025 | View | 20mg | 19mg | -5.0% | 99.63% | CD20250708 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 5 Oct 2025 | View | 20mg | 19mg | -5.0% | 99.75% | CD20250708 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 2 Oct 2025 | View | 20mg | 24.3mg | +21.5% | 100.00% | cd20250708 | White Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 30 Sep 2025 | View | 20mg | 18.9mg | -5.5% | 99.93% | CD20250708 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 30 Sep 2025 | View | 20mg | 18.9mg | -5.5% | 99.90% | CD20250708 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 30 Sep 2025 | View | 20mg | 18.5mg | -7.5% | 99.92% | CD20250708 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 30 Sep 2025 | View | 20mg | 21.9mg | +9.5% | 100.00% | CD20250708 | White Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 21 Aug 2025 | View | 20mg | 20.2mg | +1.0% | 99.95% | CD20250708 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 17 Jul 2025 | View | 30mg | 30.4mg | +1.3% | 99.95% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |